Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947604025> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2947604025 abstract "TPS3171 Background: Osimertinib (Osi) is a third-generation epidermal growth factor receptor (EGFR) – -tyrosine kinase inhibitor (TKI) that potently and selectively inhibits both EGFR-TKI sensitizing and EGFR T790M resistance mutations (mu). O showed superior efficacy compared with first generation EGFR-TKIs in patients (pts) with previously untreated advanced NSCLC harboring sensitizing EGFR mu in the prior phase III trial. Therefore, Osi is one of the most important standard therapies in EGFR mu positive pts. However, there are few reports about mechanisms of Osi resistance as the first line (1L) EGFR-TKI. Understanding of 1L Osi resistance mechanisms is essential to conduct future therapeutic strategy for EGFR mu NSCLC pts. We planned the analysis of the resistant mechanism by the ultra-sensitive next-generation sequence (NGS) using the circulating tumor (ct) DNA to clarify a resistant mechanism of 1L Osi. Methods: We prospectively collect ctDNA samples from EGFR mu positive NSCLC who will be treated with Osi as 1L. Planned enrollment is 180 cases, we estimate an analysis case at exacerbation to be 120 cases in a registration period and the observation period of for each two years. ctDNA samples are collected at treatment initiation, 3 and 12 months after Osi treatment, and disease progression. We will analyze the mechanisms of 1L Osi by the ultra-sensitive NGS using ctDNA. The key inclusion criteria are histologically or cytologically proven NSCLC, EGFR mu positive, pts treated with Osi as 1L, and written informed consent. The key exclusion criteria are patients who were deemed unsuitable for participation by an attending physician due to other conditions. The primary outcome is to clarify the incidence and ratio of Osi resistance by the ultra-sensitive NGS method using ctDNA at treatment initiation and progression disease. And key secondary endpoint is to examine how the detection quantity of the Osi resistance association mu in ctDNA at treatment initiation influences progressive disease. Clinical trial information: jRCTs031180051." @default.
- W2947604025 created "2019-06-07" @default.
- W2947604025 creator A5013472489 @default.
- W2947604025 creator A5016465101 @default.
- W2947604025 creator A5054386489 @default.
- W2947604025 creator A5066357817 @default.
- W2947604025 creator A5070574455 @default.
- W2947604025 creator A5076545273 @default.
- W2947604025 date "2019-05-20" @default.
- W2947604025 modified "2023-09-27" @default.
- W2947604025 title "Prospective observational study for treatment resistance-related gene screening using plasma circulating tumor DNA in the third generation EGFR TKI osimertinib therapy elucidator." @default.
- W2947604025 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.tps3171" @default.
- W2947604025 hasPublicationYear "2019" @default.
- W2947604025 type Work @default.
- W2947604025 sameAs 2947604025 @default.
- W2947604025 citedByCount "0" @default.
- W2947604025 crossrefType "journal-article" @default.
- W2947604025 hasAuthorship W2947604025A5013472489 @default.
- W2947604025 hasAuthorship W2947604025A5016465101 @default.
- W2947604025 hasAuthorship W2947604025A5054386489 @default.
- W2947604025 hasAuthorship W2947604025A5066357817 @default.
- W2947604025 hasAuthorship W2947604025A5070574455 @default.
- W2947604025 hasAuthorship W2947604025A5076545273 @default.
- W2947604025 hasConcept C104317684 @default.
- W2947604025 hasConcept C121608353 @default.
- W2947604025 hasConcept C126322002 @default.
- W2947604025 hasConcept C143998085 @default.
- W2947604025 hasConcept C23131810 @default.
- W2947604025 hasConcept C2777626846 @default.
- W2947604025 hasConcept C2778087573 @default.
- W2947604025 hasConcept C2779438470 @default.
- W2947604025 hasConcept C2781335228 @default.
- W2947604025 hasConcept C502942594 @default.
- W2947604025 hasConcept C54355233 @default.
- W2947604025 hasConcept C71924100 @default.
- W2947604025 hasConcept C86803240 @default.
- W2947604025 hasConceptScore W2947604025C104317684 @default.
- W2947604025 hasConceptScore W2947604025C121608353 @default.
- W2947604025 hasConceptScore W2947604025C126322002 @default.
- W2947604025 hasConceptScore W2947604025C143998085 @default.
- W2947604025 hasConceptScore W2947604025C23131810 @default.
- W2947604025 hasConceptScore W2947604025C2777626846 @default.
- W2947604025 hasConceptScore W2947604025C2778087573 @default.
- W2947604025 hasConceptScore W2947604025C2779438470 @default.
- W2947604025 hasConceptScore W2947604025C2781335228 @default.
- W2947604025 hasConceptScore W2947604025C502942594 @default.
- W2947604025 hasConceptScore W2947604025C54355233 @default.
- W2947604025 hasConceptScore W2947604025C71924100 @default.
- W2947604025 hasConceptScore W2947604025C86803240 @default.
- W2947604025 hasLocation W29476040251 @default.
- W2947604025 hasOpenAccess W2947604025 @default.
- W2947604025 hasPrimaryLocation W29476040251 @default.
- W2947604025 hasRelatedWork W2518679097 @default.
- W2947604025 hasRelatedWork W2555307561 @default.
- W2947604025 hasRelatedWork W2613582623 @default.
- W2947604025 hasRelatedWork W2761010153 @default.
- W2947604025 hasRelatedWork W2764033692 @default.
- W2947604025 hasRelatedWork W2890995598 @default.
- W2947604025 hasRelatedWork W2892128400 @default.
- W2947604025 hasRelatedWork W2906802315 @default.
- W2947604025 hasRelatedWork W2947136329 @default.
- W2947604025 hasRelatedWork W2954306104 @default.
- W2947604025 hasRelatedWork W2961009279 @default.
- W2947604025 hasRelatedWork W2971326207 @default.
- W2947604025 hasRelatedWork W2971879199 @default.
- W2947604025 hasRelatedWork W2990041408 @default.
- W2947604025 hasRelatedWork W3015062822 @default.
- W2947604025 hasRelatedWork W3028580685 @default.
- W2947604025 hasRelatedWork W3029459927 @default.
- W2947604025 hasRelatedWork W3032408353 @default.
- W2947604025 hasRelatedWork W3035982534 @default.
- W2947604025 hasRelatedWork W3095947917 @default.
- W2947604025 isParatext "false" @default.
- W2947604025 isRetracted "false" @default.
- W2947604025 magId "2947604025" @default.
- W2947604025 workType "article" @default.